Please assess the completion status of the following clinical trial:

Trial Title: Measuring Adherence to Control Hypertension

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion criteria~* established diagnosis of hypertension~* prescribed at least one blood pressure (BP) medication~* at least two consecutive clinic visits with elevated BP according to Joint National Committee (JNC-7) guidelines (i.e., BP ≥ 140/90 mmHg or ≥ 130/80 mmHg if diabetes or chronic kidney disease)~* 18 to 80 years old~* at least one prior visit with a clinician enrolled in the study~Exclusion criteria~* severe mental illness~* resided in a long-term care facility~* unable to use the electronic adherence device due to physical or cognitive impairment~* non-English or non-Spanish speaking~* unavailable for follow-up

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Concealment (control) (Type: OTHER): Clinicians in the control arm will not receive any electronically-monitored medication adherence information (collected via MedSignals pillbox) at the 1-month visit and will be expected to manage hypertension according to their usual care.
- Disclosure (intervention) (Type: EXPERIMENTAL): Disclosure of adherence report to clinician:~At clinic visits with patients with uncontrolled hypertension, clinicians in the intervention arm were provided with a quantitative summary of their patients' electronic adherence to antihypertensive medications (collected via MedSignals pillbox).

Based on this trial design, predict the completion outcome and termination type (if applicable).